Mirae Asset Global ETFs Holdings’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$64.2K Sell
57,321
-2,540
-4% -$2.85K ﹤0.01% 2814
2025
Q1
$47.3K Buy
59,861
+2,580
+5% +$2.04K ﹤0.01% 2861
2024
Q4
$94.5K Sell
57,281
-5,983
-9% -$9.87K ﹤0.01% 2725
2024
Q3
$222K Buy
63,264
+11,520
+22% +$40.4K ﹤0.01% 2329
2024
Q2
$170K Buy
+51,744
New +$170K ﹤0.01% 2338